Study of fluid leaks in serious whole-body inflammation
Treatments studied
Part of Immune system & allergy clinical trials.
This trial looks at what causes blood vessels to “leak” fluid during a dangerous whole-body inflammation response. It may help doctors understand why some people develop fluid buildup and aim for better monitoring and care in the ICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older and are in the ICU at a specific hospital (Georges Pompidou or La Pitié-Salpêtrière).
- You currently have a whole-body inflammation response (SIRS), such as fever or low body temperature, fast heartbeat, fast breathing, or abnormal blood counts.
- You are willing to take part in the study (no refusal).
- You are not pregnant.
- You do not have severe liver scarring (cirrhosis with Child-Pugh B or higher) or very underweight body mass (BMI under 15).
- You do not have nephrotic syndrome (a specific kidney condition) and are not under legal custody or guardianship restrictions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies specific body proteins to understand why fluid can leak from blood vessels during dangerous shock after infection or heart problems. If you (or your representative) qualify, your team will collect information and possibly samples to see whether these proteins relate to recovery and treatment response.
This study looks at how the body responds to extra fluids in patients with severe infections (sepsis) who are on a breathing machine. It aims to understand how fluids affect blood flow and congestion to improve treatment.
This study looks at blood “biomarkers,” or measurable body signals, in people with autoimmune diseases, vasculitis, or autoinflammatory conditions. The goal is to better understand these illnesses and how they relate to disease activity.
This study looks at how your immune system and inflammation affect your recovery in the intensive care unit. Researchers want to understand why some patients do better than others.
This study looks at blood vessel cells in three groups: healthy adults, patients having major surgery, and critically ill patients with sepsis. It aims to understand how these cells change in different types of inflammation.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
Hear when a new Systemic Inflammatory Response Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.